Liver Injury/Regeneration News

LONDON — Combined glecaprevir and pibrentasvir with ezetimibe prevented hepatitis C infection among patients who received non-liver solid organ transplants with HCV viremic grafts, according to research.

LONDON — Younger-onset type 2 diabetes increased the risk for liver-related events among patients with nonalcoholic fatty liver disease, according to research presented at the International Liver Congress.

Researchers found that psoriasis correlated with nonalcoholic fatty liver disease among adults, based on data from the National Health and Nutrition Examination Survey.

An updated MELD 3.0 amends existing sex-based disparities in access to liver transplantation among women, according to a presenter at the American Transplant Congress 2022.

SAN DIEGO — Higher sex hormone-binding globulin levels may predict liver fibrosis for men with nonalcoholic fatty liver disease, according to a presenter at the AACE Annual Scientific and Clinical Conference.

Orphalan announced FDA approval of Cuvrior for the treatment of adults with stable Wilson’s disease who are de-coppered and tolerant to penicillamine, according to a company press release.

High alcohol intake was more frequent following early liver transplant vs. standard transplant in patients with severe alcohol-related hepatitis, according to research published in The Lancet Gastroenterology and Hepatology.

Machine learning models, compared with traditional models, demonstrated good performance in the prediction of short-term prognosis following liver transplant in patients with acute-on-chronic liver failure, according to research.

The majority of liver transplant recipients are able to produce a functional antibody response to COVID-19 infection, according to data published in Gut.

Healio presents the following report on the top 10 hepatology peer-tested articles from 2021.